- Obama takes aim at ‘corporate deserters’
- Dick’s Sporting Goods lays off 478 PGA golf pros
- Senators: Cease-fire must allow Israel to defend against rockets, tunnels
- Sierra Leone doctor fighting Ebola catches disease
- Iraq welcomes Russian fighter jets, helicopter gunships into ISIL fight
- John McCain laments: Obama’s ‘self-pity … is really kind of sad’
- GOP offer to fix VA gives $10 billion in emergency funds
- Paul Ryan offers to repair U.S. economic safety net with a single grant stream
- Kim Jong-un builds bond with Putin: $250M Russia-backed addition to key port opens
- Pope Francis meets Meriam Ibrahim, a Sudanese woman sentenced to death
Ga. moves forward on medicinal marijuana study
Question of the Day
AUGUSTA, Ga. (AP) - Researchers at Georgia Regents University will study a product derived from marijuana that could be used to treat children who suffer from seizures, under a new agreement between the university, the state and a pharmaceutical company.
Epidolex is a GW Pharmaceuticals investigational product that uses cannabidiol, a marijuana extract also known as CBD that doesn’t get users high, university officials said in a written statement Tuesday.
The plan for the state university study came after lawmakers failed to pass a bill during the 2014 session allowing limited medical use of cannabidiol in Georgia.
GW Pharmaceuticals Chairman Geoffrey Guy said Georgia Regents University, which is home to the Medical College of Georgia, has the experience, expertise and infrastructure to launch the study with the scientific and regulatory standards in mind.
Guy called the collaboration an opportunity for Georgians to get solid scientific data to help them understand “how CBD works in such a challenging and vulnerable patient population.”
The Food and Drug Administration has already authorized clinical trials involving Epidolex at 12 sites across the country involving more than 300 children, Georgia Regents University officials said.
“I’m grateful to Georgia Regents University and GW Pharmaceuticals for their leadership on this venture, and I’m confident that this public-partnership will deliver relief and improve quality of life for these children and their families,” Gov. Nathan Deal said in a written statement.
GW Pharmaceuticals was founded in 1998 and is based in the United Kingdom. The company specializes in developing and researching medicines that contain controlled substances and plant-based medications.
TWT Video Picks
Second- and third-stringers eye 2016 if front-runner stumbles
- 'We're coming for you, Barack Obama': Top U.S. official discloses threat from ISIL terrorists
- Obama orders Pentagon advisers to Ukraine
- NAPOLITANO: What if our democracy is a fraud?
- Hamas rejects Kerry's call for cease-fire; Fears grow others could join fight against Israel
- State Department indicates Nouri al-Maliki's days numbered as Iraq prime minister
- Inside China: Massive flight woes and a missile test
- Algerian plane diverted due to storms, second aircraft: 116 missing
- Evidence shows Russia firing artillery into Ukraine: Pentagon
- Obama family set to buy $4.25M desert home in California: report
- Norway expects imminent 'concrete threat' from ISIL terrorists 'within days'
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq